Zero-trust architecture, in which everything is treated as a potential threat, is becoming the norm in industry. Our expert suggests it’s time to make the consumer a part of that framework.
Pharmaceutical companies have tried to monitor their suppliers and verify the authenticity of their supply chain, but full protection has been difficult — until now.
